GILEAD SCIENCES, INC.
$167.58
−0.50 (−0.30%) · delayed · Nov 16, 2026
Five-year price
52w $116.88 to $176.58
- Market cap
- $207.9B
- Enterprise value
- $225.2B
- P/E
- 24.7×
- 43.1× on 3y avg EPS
- EV / EBIT
- 22.5×
- FCF yield
- 4.5%
- ROIC
- 21.7%
- Debt / equity
- 1.10
- Piotroski F
- 7/9
Value scorecard · FY2025
Does it pass the value tests?
Quality
- ●ROIC > 12% (5y avg)5y avg ROIC 14.3%
- ●ROE > 15% (5y avg)5y avg ROE 23.2%
- ○Stable operating marginsMargin volatility 10.8% (σ, 5y)
- ●Earnings convert to cashFCF / net income 549% (5y avg)
- ●Growing revenueRevenue CAGR 5y 3.6%
- ●Shrinking share countDiluted shares -0.6% over 5y
Value
- ○P/E below 15P/E 24.7
- ○EV/EBIT below 12EV/EBIT 22.5
- ○FCF yield above 6%FCF yield 4.5%
- ○Price below Graham NumberGraham Number $52.84
- ○P/B below 3P/B 9.2
Safety
- ○Debt / equity below 0.5D/E 1.10
- ●Debt payable in < 4 yrs of earningsNet debt $17.4B
- ●Interest coverage > 8xCoverage 9.8x
- ●Current ratio > 1.5Current ratio 1.55
- ●Piotroski F-score ≥ 6F-score 7/9
Graham Defensive
- ●Adequate size (revenue > $2B)Revenue $29.4B
- ○Strong condition (current ratio ≥ 2)Current ratio 1.55
- ●Earnings stability (no loss, 10y)10 years of data
- ●Uninterrupted dividendsDividends paid every year on record
- ○Earnings growth ≥ 33% (10y, 3y avgs)EPS growth -34%
- ○Moderate P/E (≤ 15 on 3y avg EPS)P/E (3y avg) 43.1
- ○P/E × P/B ≤ 22.5Product 394.8
Valuation lab
What do you have to believe?
At $167.58, the market is pricing in about 8.0% annual free-cash-flow growth for the next decade (9% discount rate, 2.5% terminal growth).
Starting cash flow
Net debt $17.4B · 1240M shares · 5y revenue CAGR 3.6%
Intrinsic value
$120.59
Price
$167.58
Premium paid
39%
What the price implies
The market is paying for 8.0% annual cash-flow growth for 10 years at a 9.0% discount rate.
Terminal value share
56% of the value sits beyond year 10.
Financial statements
A decade of the record.
USD millions · fiscal years · source: SEC 10-K XBRL
| Line item | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 30,390 | 26,107 | 22,127 | 22,449 | 24,689 | 27,305 | 27,281 | 27,116 | 28,754 | 29,443 |
| Gross profit | — | — | — | — | — | — | — | — | — | — |
| Operating income | 17,633 | 14,124 | 8,200 | 4,287 | 4,071 | 9,918 | 7,330 | 7,605 | 1,662 | 10,022 |
| Operating margin | 58.0% | 54.1% | 37.1% | 19.1% | 16.5% | 36.3% | 26.9% | 28.0% | 5.8% | 34.0% |
| Pre-tax income | 17,097 | 13,529 | 7,799 | 5,160 | 1,669 | 8,278 | 5,814 | 6,859 | 690 | 9,796 |
| Income tax | 3,609 | 8,885 | 2,339 | (204) | 1,580 | 2,077 | 1,248 | 1,247 | 211 | 1,286 |
| Net income | 13,501 | 4,628 | 5,455 | 5,386 | 123 | 6,225 | 4,592 | 5,665 | 480 | 8,510 |
| EPS (diluted) | 9.94 | 3.51 | 4.17 | 4.22 | 0.10 | 4.93 | 3.64 | 4.50 | 0.38 | 6.78 |
| Diluted shares | 1,358 | 1,319 | 1,308 | 1,277 | 1,263 | 1,262 | 1,262 | 1,258 | 1,255 | 1,255 |
Who owns it